Results 11 to 20 of about 7,977 (217)
Cabergoline Treatment in Invasive Giant Prolactinoma
Clinical Medicine Insights: Case Reports, 2014 Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive
Sadeem Alsubaie, Mussa H. Almalki
doaj +2 more sources
Prolactinoma presenting as chronic anaemia with osteoporosis: a case report [PDF]
Journal of Medical Case Reports, 2010 Introduction Unexplained anaemia is a rare mode of presentation for prolactinoma. We describe a case of a man, with chronic anaemia ascribed to old age.
Hanley John P, MacLean Fergus R
doaj +3 more sources
Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia
Iatreia, 2016 Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic
López-Clavijo, Carlos Alberto +3 more
doaj +2 more sources
Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis
Open Chemistry, 2019 Resistance to Dopamine agonists therapy is still a key factor that hinders the clinical treatment of prolactinoma. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets.
Lan Xiaolei +4 more
doaj +2 more sources
Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients [PDF]
Gazi Medical JournalObjective: There may be an association between hyperprolactinemia and autoimmune diseases, possibly because of the immunostimulatory effect of prolactin.
Özlem Kanburoğlu Meletli +8 more
doaj +2 more sources
Evaluation of Hyperandrogenemia in Women with Prolactinoma
Endocrinology Research and Practice, 2020 Objective: Differential diagnosis of androgen excess disorders revealed the occurrence of hyperprolactinemia. However, an elevated level of prolactin (hyperprolactinemia) is a very infrequent cause of hyperandrogenemia in clinical practice.
Mehmet Çağrı ÜNAL +3 more
doaj +2 more sources
Przeglad lekarski, 2009 Prolactin-secreting tumours (prolactinomas) are benign neoplasms constituting about 40 percent of all pituitary tumours. The incidence of these tumours varies with age and sex, occurring most frequently in females between 20 and 40-years-old. The clinical symptoms of prolactinomas are menstrual dysfunction and galactorrhea in women and loss of libido ...
Robert, Krysiak +3 more
openaire +2 more sources
Prolactinoma Concomitante a un Caso de Glaucoma Primario de Ángulos Abiertos, a propósito de un Caso [PDF]
Revista OftálmicaEn la práctica clínica oftalmológica diaria es frecuente evaluar pacientes que presentan Glaucoma primario de ángulos abiertos1,2. En algunos casos se pueden presentar adicionalmente lesiones en nervio óptico de origen intracraneal4.
Oscar Guillermo Márquez Valdez
doaj +2 more sources
La Presse Médicale, 2021 Hyperprolactinemia, defined by a level of serum prolactin above the standard upper limit of normal range, is a common finding in clinical practice and prolactinomas are the main pathological cause. Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including ...
Luiz Eduardo Wildemberg +2 more
openaire +2 more sources
Arquivos Brasileiros de Endocrinologia & Metabologia, 2014 Os prolactinomas são os adenomas de hipófise mais comuns e frequentemente afetam mulheres jovens, em faixa etária de fertilidade. A hiperprolactinemia causa hipogonadismo, irregularidade menstrual ou amenorreia em mulheres, níveis baixos de testosterona sérica em homens e infertilidade e disfunção sexual em ambos os gêneros.
Glezer, Andrea, Bronstein, Marcello D.
openaire +4 more sources